Cronin N B, Badasso M O, J Tickle I, Dreyer T, Hoover D J, Rosati R L, Humblet C C, Lunney E A, Cooper J B
Department of Crystallography, Birkbeck College, University of London, London, WC1E 7HX, UK.
J Mol Biol. 2000 Nov 10;303(5):745-60. doi: 10.1006/jmbi.2000.4181.
Saccharopepsin is a vacuolar aspartic proteinase involved in activation of a number of hydrolases. The enzyme has great structural homology to mammalian aspartic proteinases including human renin and we have used it as a model system to study the binding of renin inhibitors by X-ray crystallography. Five medium-to-high resolution structures of saccharopepsin complexed with transition-state analogue renin inhibitors were determined. The structure of a cyclic peptide inhibitor (PD-129,541) complexed with the proteinase was solved to 2.5 A resolution. This inhibitor has low affinity for human renin yet binds very tightly to the yeast proteinase (K(i)=4 nM). The high affinity of this inhibitor can be attributed to its bulky cyclic moiety spanning P(2)-P(3)' and other residues that appear to optimally fit the binding sub-sites of the enzyme. Superposition of the saccharopepsin structure on that of renin showed that a movement of the loop 286-301 relative to renin facilitates tighter binding of this inhibitor to saccharopepsin. Our 2.8 A resolution structure of the complex with CP-108,420 shows that its benzimidazole P(3 )replacement retains one of the standard hydrogen bonds that normally involve the inhibitor's main-chain. This suggests a non-peptide lead in overcoming the problem of susceptible peptide bonds in the design of aspartic proteinase inhibitors. CP-72,647 which possesses a basic histidine residue at P(2), has a high affinity for renin (K(i)=5 nM) but proves to be a poor inhibitor for saccharopepsin (K(i)=3.7 microM). This may stem from the fact that the histidine residue would not bind favourably with the predominantly hydrophobic S(2) sub-site of saccharopepsin.
蔗糖胃蛋白酶是一种液泡天冬氨酸蛋白酶,参与多种水解酶的激活。该酶与包括人肾素在内的哺乳动物天冬氨酸蛋白酶具有高度的结构同源性,我们已将其用作模型系统,通过X射线晶体学研究肾素抑制剂的结合。确定了与过渡态类似物肾素抑制剂复合的蔗糖胃蛋白酶的五个中高分辨率结构。一种与蛋白酶复合的环肽抑制剂(PD - 129,541)的结构解析到了2.5埃的分辨率。这种抑制剂对人肾素的亲和力较低,但与酵母蛋白酶紧密结合(K(i)=4 nM)。这种抑制剂的高亲和力可归因于其跨越P(2)-P(3)'的庞大环状部分以及其他似乎能最佳适配该酶结合亚位点的残基。将蔗糖胃蛋白酶的结构与肾素的结构叠加显示,相对于肾素,环286 - 301的移动促进了这种抑制剂与蔗糖胃蛋白酶的更紧密结合。我们解析的与CP - 108,420复合物的2.8埃分辨率结构表明,其苯并咪唑P(3)取代基保留了通常涉及抑制剂主链的标准氢键之一。这表明在天冬氨酸蛋白酶抑制剂设计中,一种非肽类先导物可克服易受影响的肽键问题。在P(2)处具有碱性组氨酸残基的CP - 72,647对肾素具有高亲和力(K(i)=5 nM),但事实证明它对蔗糖胃蛋白酶是一种较差的抑制剂(K(i)=3.7 microM)。这可能源于组氨酸残基与蔗糖胃蛋白酶主要为疏水性的S(2)亚位点结合不利这一事实。